![]() |
| |||||||||||||
![]() |
|
![]() New Milestones in Cancer Research and Education at Memorial Sloan-Kettering Cancer CenterThese major developments in the pursuit of innovative cancer research and education were celebrated with a trilogy of events from September 19 - 21, 2006 at MSKCC. "Achieving the medical promise of cancer research requires a deeper understanding of the biology of cancer and imaginative application of new knowledge in the clinic," said MSKCC President Harold Varmus. "The expansion of our research and educational programs to better understand the genetic and biochemical mechanisms by which cancers arise and behave will lead to improvements in detecting, classifying, monitoring, and treating cancer."
Memorial Sloan-Kettering has nearly doubled the size of its
The first new research facility for MSKCC since 1989, The Mortimer B. Zuckerman Research Center's 23-story building is
A three-day celebration of public lectures ended with an open house at the Zuckerman Research Center on September 21 not only recognized the official opening of the new research facility, but also celebrates the inaugural class of the Louis V. Gerstner, Jr. Sloan-Kettering Graduate School of Biomedical Sciences, and acknowledges the establishment a novel research program in human oncology, the Human Oncology and Pathogenesis Program (HOPP).
The new graduate school offers a novel doctoral program that trains basic laboratory scientists to work in research areas directly applicable to human disease and, in particular, cancer. HOPP is a major hospital-based initiative in which scientists and physicians aim to translate laboratory findings into novel approaches to cancer detection, diagnosis, treatment, and prevention. Both of these programs are housed in The Mortimer B. Zuckerman Research Center, located across the street from Memorial Hospital.The proximity encourages interdisciplinary efforts as scientists and physicians work in concert to achieve a better understanding of cancer and develop new, more effective ways of controlling the disease. These laboratories will accommodate the Center's programs inimmunology, molecular pharmacology and chemistry, and cancer biology and genetics. The facility will also include shared core laboratory facilities such as high-through put drug screening to identify small-molecule drug candidates and nuclear magnetic resonance that will provide crucial equipment and technical support for work conducted by multiple programs. The connecting seven-story structure will add a conference center with a 350-seat auditorium and a number of "dry" laboratories, including space for computational biology.
The research facility features a strong emphasis on energy-efficiency and environmental sustainability and it is expected to be among the first research buildings in New York State to receive certification from the Leadership in Energy and Environmental Design (LEED®) GreenBuilding Rating System™, a benchmarking standard developed by the U.S. Green Building Council that evaluates the environmental performance of buildings. LEED® certification recognizes aconstruction approach that optimizes environmental and economic factors such as water savings, energy efficiency, materials selection, and indoor environmental quality.
Designed by Skidmore, Owings & Merrill LLP in collaborationwith the Zimmer Gunsul Frasca Partnership, the facility was built byTurner Construction Company under the direction of MemorialSloan-Kettering's Facilities Management. Construction began with the groundbreaking in the spring of 2002 and the first occupants moved into the building in May 2006.
|
||||||||||||||||||||||||||||||||||||||||||
|
| ||||||